330 related articles for article (PubMed ID: 38206553)
21. microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts.
Schulte C; Zeller T
Cardiovasc Diagn Ther; 2015 Feb; 5(1):17-36. PubMed ID: 25774345
[TBL] [Abstract][Full Text] [Related]
22. Small Molecules with Big Impacts on Cardiovascular Diseases.
Mirzadeh Azad F; Arabian M; Maleki M; Malakootian M
Biochem Genet; 2020 Jun; 58(3):359-383. PubMed ID: 31997044
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction.
Schulte C; Westermann D; Blankenberg S; Zeller T
World J Cardiol; 2015 Dec; 7(12):843-60. PubMed ID: 26730290
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA208 family in cardiovascular diseases: therapeutic implication and potential biomarker.
Huang Y; Li J
J Physiol Biochem; 2015 Sep; 71(3):479-86. PubMed ID: 25840809
[TBL] [Abstract][Full Text] [Related]
25. MicroRNAs as biomarkers in spontaneous intracerebral hemorrhage: A systematic review of recent clinical evidence.
Sultan W; Machado LGDD; Ali MG; Tramontana A; Bayoumy AE; Baxter SG; Aly MRA; Bilotta F
Clin Neurol Neurosurg; 2022 Feb; 213():107130. PubMed ID: 35066247
[TBL] [Abstract][Full Text] [Related]
26. Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Cardiovascular and Cerebrovascular Diseases.
Li M; Zhang J
Biomed Res Int; 2015; 2015():730535. PubMed ID: 26180810
[TBL] [Abstract][Full Text] [Related]
27. Extracellular microRNA: a new source of biomarkers.
Etheridge A; Lee I; Hood L; Galas D; Wang K
Mutat Res; 2011 Dec; 717(1-2):85-90. PubMed ID: 21402084
[TBL] [Abstract][Full Text] [Related]
28. [MicroRNAs: a role in the development of cardiovascular disease, the possibility for clinical application.].
Velikiy DA; Gichkun OE; Shevchenko AO
Klin Lab Diagn; 2018; 63(7):403-409. PubMed ID: 30720954
[TBL] [Abstract][Full Text] [Related]
29. miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease.
Schulte C; Molz S; Appelbaum S; Karakas M; Ojeda F; Lau DM; Hartmann T; Lackner KJ; Westermann D; Schnabel RB; Blankenberg S; Zeller T
PLoS One; 2015; 10(12):e0145930. PubMed ID: 26720041
[TBL] [Abstract][Full Text] [Related]
30. MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives.
Hochreuter MY; Dall M; Treebak JT; Barrès R
Mol Metab; 2022 Nov; 65():101581. PubMed ID: 36028120
[TBL] [Abstract][Full Text] [Related]
31. Circulating MicroRNAs as Novel Biomarkers in Risk Assessment and Prognosis of Coronary Artery Disease.
Vavassori C; Cipriani E; Colombo GI
Eur Cardiol; 2022 Feb; 17():e06. PubMed ID: 35321524
[TBL] [Abstract][Full Text] [Related]
32. A critical approach for successful use of circulating microRNAs as biomarkers in cardiovascular diseases: the case of hypertrophic cardiomyopathy.
Ntelios D; Georgiou E; Alexouda S; Malousi A; Efthimiadis G; Tzimagiorgis G
Heart Fail Rev; 2022 Jan; 27(1):281-294. PubMed ID: 33656618
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases.
Li S; Liang Z; Xu L; Zou F
Mol Cell Biochem; 2012 Jan; 360(1-2):147-58. PubMed ID: 21909994
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-143/-145 in Cardiovascular Diseases.
Zhao W; Zhao SP; Zhao YH
Biomed Res Int; 2015; 2015():531740. PubMed ID: 26221598
[TBL] [Abstract][Full Text] [Related]
35. Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases.
Kondkar AA; Abu-Amero KK
Biomed Res Int; 2015; 2015():821823. PubMed ID: 25710029
[TBL] [Abstract][Full Text] [Related]
36. Platelet miRNAs and cardiovascular diseases.
Fuentes E; Palomo I; Alarcón M
Life Sci; 2015 Jul; 133():29-44. PubMed ID: 26003375
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases.
Sayed AS; Xia K; Salma U; Yang T; Peng J
Heart Lung Circ; 2014 Jun; 23(6):503-10. PubMed ID: 24726001
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA Signature and Cardiovascular Dysfunction.
Arunachalam G; Upadhyay R; Ding H; Triggle CR
J Cardiovasc Pharmacol; 2015 May; 65(5):419-29. PubMed ID: 25384197
[TBL] [Abstract][Full Text] [Related]
39. The Salivary miRNome: A Promising Biomarker of Disease.
Tomei S; Manjunath HS; Murugesan S; Al Khodor S
Microrna; 2021; 10(1):29-38. PubMed ID: 33845754
[TBL] [Abstract][Full Text] [Related]
40. Regulatory RNAs and cardiovascular disease - with a special focus on circulating microRNAs.
Dlouhá D; Hubáček JA
Physiol Res; 2017 Apr; 66(Suppl 1):S21-S38. PubMed ID: 28379027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
